Anti-CD44 Antibodies Inhibit Both mTORC1 and mTORC2 Activities in Acute Myeloid Leukemia.

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Anti-CD44 Antibodies Inhibit Both mTORC1 and mTORC2 Activities in Acute Myeloid Leukemia.'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science